BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 18568996)

  • 21. Primitive peripheral neuroectodermal tumors Mayagüez Medical Center experience.
    Camps JI; Ortiz VN; Trujillo O
    Bol Asoc Med P R; 1998; 90(4-6):79-81. PubMed ID: 9866272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinico-pathologic study of Ewing's sarcomas of bone and soft tissue and peripheral primitive neuroectodermal tumors].
    Na J; Li J; Fang Z
    Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):71-3. PubMed ID: 10921066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osseous primitive neuroectodermal tumor--a case report.
    Baba Y; Ohkubo K; Seino N; Churei H; Imakiire T; Nakajo M
    Radiat Med; 1998; 16(4):297-300. PubMed ID: 9814426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ewing sarcoma/primitive neuroectodermal tumor of the kidney: a case report. Diagnosed by immunohistochemistry and molecular analysis.
    Saxena R; Sait S; Mhawech-Fauceglia P
    Ann Diagn Pathol; 2006 Dec; 10(6):363-6. PubMed ID: 17126256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small cell tumors of bone.
    Li S; Siegal GP
    Adv Anat Pathol; 2010 Jan; 17(1):1-11. PubMed ID: 20032633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetylcholine receptor expression in Merkel cell carcinoma.
    Bowers JW; Schlauder SM; Calder KB; Morgan MB
    Am J Dermatopathol; 2008 Aug; 30(4):340-3. PubMed ID: 18645305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tumors of the Ewing/PNET sarcoma family].
    Pettinato G
    Pathologica; 2003 Oct; 95(5):241-2. PubMed ID: 14988992
    [No Abstract]   [Full Text] [Related]  

  • 28. Expression of podoplanin in human bone and bone tumors: New marker of osteogenic and chondrogenic bone tumors.
    Ariizumi T; Ogose A; Kawashima H; Hotta T; Li G; Xu Y; Umezu H; Sugai M; Endo N
    Pathol Int; 2010 Mar; 60(3):193-202. PubMed ID: 20403045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-like growth factor I receptor-mediated circuit in Ewing's sarcoma/peripheral neuroectodermal tumor: a possible therapeutic target.
    Scotlandi K; Benini S; Sarti M; Serra M; Lollini PL; Maurici D; Picci P; Manara MC; Baldini N
    Cancer Res; 1996 Oct; 56(20):4570-4. PubMed ID: 8840962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for activation of KIT, PDGFRalpha, and PDGFRbeta receptors in the Ewing sarcoma family of tumors.
    Bozzi F; Tamborini E; Negri T; Pastore E; Ferrari A; Luksch R; Casanova M; Pierotti MA; Bellani FF; Pilotti S
    Cancer; 2007 Apr; 109(8):1638-45. PubMed ID: 17342771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics.
    Kikuta K; Tochigi N; Shimoda T; Yabe H; Morioka H; Toyama Y; Hosono A; Beppu Y; Kawai A; Hirohashi S; Kondo T
    Clin Cancer Res; 2009 Apr; 15(8):2885-94. PubMed ID: 19351769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new molecular variant of desmoplastic small round cell tumor: significance of WT1 immunostaining in this entity.
    Murphy AJ; Bishop K; Pereira C; Chilton-MacNeill S; Ho M; Zielenska M; Thorner PS
    Hum Pathol; 2008 Dec; 39(12):1763-70. PubMed ID: 18703217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High expression of neuropeptide Y1 receptors in ewing sarcoma tumors.
    Körner M; Waser B; Reubi JC
    Clin Cancer Res; 2008 Aug; 14(16):5043-9. PubMed ID: 18698022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of papillomavirus binding factor in Ewing's sarcoma family of tumors conferring poor prognosis.
    Yabe H; Tsukahara T; Kawaguchi S; Wada T; Sato N; Morioka H; Yabe H
    Oncol Rep; 2008 Jan; 19(1):129-34. PubMed ID: 18097586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution.
    Hornick JL; Fletcher CD
    Am J Clin Pathol; 2002 Feb; 117(2):188-93. PubMed ID: 11865845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of tumor protein D52 immunostaining in a large series of Ewing's sarcoma family of tumors.
    Machado I; López-Guerrero JA; Calabuig-Fariñas S; Hardy JR; Scotlandi K; Picci P; Byrne JA; Llombart-Bosch A
    Pediatr Dev Pathol; 2011; 14(3):255-6. PubMed ID: 21338318
    [No Abstract]   [Full Text] [Related]  

  • 37. Localised Ewing sarcoma/PNET of bone--prognostic factors and international data comparison.
    Jenkin RD; Al-Fawaz I; Al-Shabanah M; Allam A; Ayas M; Khafaga Y; Memon M; Rifai S; Schultz H; Younge D
    Med Pediatr Oncol; 2002 Dec; 39(6):586-93. PubMed ID: 12376982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary Ewing sarcoma/PNET of the kidney: fine-needle aspiration, histology, and dual color break apart FISH Assay.
    Kang SH; Perle MA; Nonaka D; Zhu H; Chan W; Yang GC
    Diagn Cytopathol; 2007 Jun; 35(6):353-7. PubMed ID: 17497665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary Ewing sarcoma/peripheral primitive neuroectodermal tumor of the vulva.
    Fong YE; López-Terrada D; Zhai QJ
    Hum Pathol; 2008 Oct; 39(10):1535-9. PubMed ID: 18602673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics.
    Foo WC; Cruise MW; Wick MR; Hornick JL
    Am J Clin Pathol; 2011 Jun; 135(6):839-44. PubMed ID: 21571956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.